Skip to content

Effect of Drakshaharitakyadi churna

Clinical Evaluation of Drakshaharitakyadi Churna in Childhood Tamaka Shwasa - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074493
Enrollment
40
Registered
2024-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

None listed

Sponsors

Rishikul Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Intermittent and Mild cases of Asthma according to Global Initiative for Asthma (GINA) guidelines

Exclusion criteria

Exclusion criteria: Moderate to Severe asthma according to Global Initiative for Asthma(GINA)guidelines • Patients with known case of HIV, TB, Hep-B & Frequent H/O hospitalization due to status asthmatics

Design outcomes

Primary

MeasureTime frame
Clinical Evaluation of Drakshaharitakayadi Churna in the management of Childhood Tamaka Shwasa Subjectively all signs & symptoms are given with grading depending upon their severity Timepoint: 15 days

Secondary

MeasureTime frame
Clinical Evaluation of Drakshaharitakayadi Churna in the management of Childhood Tamaka Shwasa Subjectively all signs & symptoms are given with grading depending upon their severity Timepoint: 2 weeks

Countries

India

Contacts

Public ContactDr Keerti Verma

Rishikul Campus,Haridwar

keerti.vrm@gmail.com9997777833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026